Showing results (631-640 of 1,855) with videos related to
Sort By:
Pageof 186
The American Journal of Drug and Alcohol Abuse|March 27, 2009
Self-report of drinking compared to objective markers of alcohol consumptionJennifer L Whitford, Sabina C Widner, Davis Mellick, et al.The International Journal of Clinical and Experimental Hypnosis|December 7, 2023
Exploring Variables Associated with the Effects of a Self-Administered Hypnosis Intervention for Improving Sleep QualityCameron T Alldredge, Morgan Snyder, Samuel R Stork, et al.The Iowa Orthopaedic Journal|June 29, 2023
'Tis Time 'Tis Time: The Importance of Operative Time, Thoroughness, and Shakespeare in Dair Procedures in Total Joint ArthroplastyMichael C Marinier, Bryan Mouser, Ayobami S Ogunsola, et al.Plos One|March 27, 2023
IL-12p40 is essential but not sufficient for Francisella tularensis LVS clearance in chronically infected miceLara R Mittereder, Jonathan Swoboda, Roberto De Pascalis, et al.Journal of the American Dental Association (1939)|April 15, 2026
Impact of obesity on clinical outcome of nonsurgical periodontal therapy in patients with periodontitis: A meta-analysisSahar Dowlatshahi, Chun-Teh Lee, Maria Elkins, et al.Child: Care, Health and Development|November 27, 2018
A family affair: Supporting children with chronic illnessesLaura Nabors, Melissa Liddle, Myia L Graves, et al.The Journal of Eukaryotic Microbiology|June 10, 2022
Sterols of Testudodinium testudo (formerly Amphidinium testudo): Production of the Δ8 (14) sterol gymnodinosterol and chemotaxonomic relationship to the KareniaceaeJeffrey D Leblond, Lindsey C Elkins, Kyra Sabir, et al.Neurology|May 25, 2005
Cognitive function predicts first-time stroke and heart diseaseJacob S Elkins, David S Knopman, Kristine Yaffe, et al.Microbes and Infection|March 4, 2006
Myeloid differentiation factor-88 (MyD88) is essential for control of primary in vivo Francisella tularensis LVS infection, but not for control of intra-macrophage bacterial replicationCarmen M Collazo, Alan Sher, Anda I Meierovics, et al.Proceedings of the National Academy of Sciences of the United States of America|March 29, 1994
Vaccines for bacterial sexually transmitted infections: a realistic goal?P F Sparling, C Elkins, P B Wyrick, et al.Pageof 186